A New Protocol for Continuous Vancomycin Infusion Dosing.

NCT05143645 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2021-12-03

No results posted yet for this study

Summary

This observational study prospectively collect data on chosen dosing, renal function, measured plasma concentrations and adherence to the recommended clinical protocl for ICU patients treated with continuous vancomycin infusion.

Conditions

Interventions

OTHER

Plasma vancoymcin measurements

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-01
Primary Completion
2020-03-31
Completion
2020-03-31
FDA Drug
Yes

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143645 on ClinicalTrials.gov